Kv1.3 Therapeutics is Drug Discovery in United States that focus on biopharmaceutical services business. Founded in 2017. They cover business area such as owner, operator, biopharmaceutical company, new treatment option, rare disease, inclusion body myositis, compound, medical researcher, drug, rare autoimmune disease.
2017
( 7 years old in 2024 )
Biopharmaceutical Services
-
219 Terry Avenue North
Suite 300
Seattle, WA 98092
United States
Private
owneroperatorbiopharmaceutical companynew treatment optionrare diseaseinclusion body myositiscompoundmedical researcherdrugrare autoimmune disease
* We use standard office opening hours in near Kv1.3 Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Kv1.3 Therapeutics is Drug Discovery business from United States that founded in 2017 (7 years old in 2024), Kv1.3 Therapeutics business is focusing on Biopharmaceutical Services.
Kv1.3 Therapeutics headquarter office and corporate office address is located in 219 Terry Avenue North Suite 300 Seattle, WA 98092 United States.
Kv1.3 Therapeutics was founded in United States.
In 2024, Kv1.3 Therapeutics is currently focus on biopharmaceutical services sector.
Above is snippet of Google Trends for "biopharmaceutical services" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Kv1.3 Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
